Lee, Danner & Bass’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152M Buy
390,240
+2,863
+0.7% +$1.21M 8.77% 1
2026
Q1
$183M Sell
387,377
-499
-0.1% -$251K 11.52% 1
2025
Q4
$181M Sell
387,876
-5,778
-1% -$2.68M 12.98% 1
2025
Q3
$168M Sell
393,654
-3,242
-0.8% -$1.26M 12.21% 1
2025
Q2
$152M Sell
396,896
-3,523
-0.9% -$1.27M 11.83% 1
2025
Q1
$138M Sell
400,419
-2,234
-0.6% -$719K 11.19% 2
2024
Q4
$121M Sell
402,653
-3,237
-0.8% -$1.13M 9.58% 2
2024
Q3
$165M Sell
405,890
-3,496
-0.9% -$1.28M 11.62% 1
2024
Q2
$132M Buy
+409,386
New +$133M 10.14% 1
2023
Q4
$113M Sell
416,591
-10,535
-2% -$2.6M 9.66% 1
2023
Q3
$105M Buy
427,126
+780
+0.2% +$213K 9.51% 2
2023
Q2
$129M Sell
426,346
-4,152
-1% -$1.15M 11.13% 1
2023
Q1
$114M Sell
430,498
-7,477
-2% -$1.9M 10.44% 1
2022
Q4
$105M Sell
437,975
-1,444
-0.3% -$323K 9.91% 1
2022
Q3
$80.8M Sell
439,419
-3,770
-0.9% -$751K 8.54% 2
2022
Q2
$74.5M Buy
443,189
+6,935
+2% +$1.49M 7.52% 2
2022
Q1
$109M Sell
436,254
-1,987
-0.5% -$499K 9.32% 2
2021
Q4
$113M Sell
438,241
-5,634
-1% -$1.38M 9.64% 1
2021
Q3
$108M Sell
443,875
-21,304
-5% -$5.21M 9.94% 1
2021
Q2
$96.2M Sell
465,179
-13,295
-3% -$2.71M 8.71% 2
2021
Q1
$90.1M Sell
478,474
-1,852
-0.4% -$327K 8.68% 2
2020
Q4
$79M Sell
480,326
-12,033
-2% -$1.76M 8.42% 2
2020
Q3
$61.4M Sell
492,359
-3,490
-0.7% -$432K 7.27% 2
2020
Q2
$48.1M Buy
495,849
+18,790
+4% +$1.95M 6.14% 2
2020
Q1
$42.9M Buy
477,059
+1,512
+0.3% +$196K 6.13% 2
2019
Q4
$70.3M Sell
475,547
-12,025
-2% -$1.61M 7.35% 2
2019
Q3
$58.7M Sell
487,572
-831
-0.2% -$107K 6.3% 3
2019
Q2
$66M Sell
488,403
-10,114
-2% -$1.28M 6.98% 3
2019
Q1
$65M Sell
498,517
-14,539
-3% -$1.95M 7.16% 3
2018
Q4
$63.9M Sell
513,056
-10,995
-2% -$1.48M 7.52% 2
2018
Q3
$72.9M Sell
524,051
-13,630
-3% -$1.7M 7.23% 3
2018
Q2
$55.2M Sell
537,681
-27,931
-5% -$2.83M 5.87% 3
2018
Q1
$54.9M Buy
565,612
+200,010
+55% +$19.4M 5.71% 3
2017
Q4
$32.1M Sell
365,602
-42,216
-10% -$3.39M 3.26% 4
2017
Q3
$32.5M Buy
407,818
+3,186
+0.8% +$256K 3.49% 4
2017
Q2
$35.3M Buy
404,632
+1,828
+0.5% +$155K 3.96% 3
2017
Q1
$35.8M Sell
402,804
-26,242
-6% -$2.19M 4.04% 3
2016
Q4
$31.8M Sell
429,046
-16,075
-4% -$1.2M 3.73% 4
2016
Q3
$33.7M Sell
445,121
-1,375
-0.3% -$105K 4.1% 3
2016
Q2
$34.4M Sell
446,496
-7,875
-2% -$622K 4.16% 3
2016
Q1
$36.9M Sell
454,371
-3,946
-0.9% -$276K 4.53% 3
2015
Q4
$31M Buy
458,317
+8,600
+2% +$600K 4.06% 3
2015
Q3
$34.8M Sell
449,717
-69,730
-13% -$6.17M 4.64% 3
2015
Q2
$47.1M Sell
519,447
-43,550
-8% -$3.49M 5.62% 3
2015
Q1
$42.4M Buy
562,997
+28,435
+5% +$2.04M 5% 3
2014
Q4
$39.2M Sell
534,562
-4,745
-0.9% -$333K 4.69% 3
2014
Q3
$38M Sell
539,307
-149,350
-22% -$9.87M 4.7% 3
2014
Q2
$38.8M Sell
688,657
-14,434
-2% -$762K 4.73% 3
2014
Q1
$36.9M Sell
703,091
-36,575
-5% -$1.82M 4.79% 3
2013
Q4
$35.3M Sell
739,666
-154,885
-17% -$7.16M 4.71% 3
2013
Q3
$38.2M Sell
894,551
-91,510
-9% -$3.58M 5.32% 3
2013
Q2
$35.6M Buy
+986,061
New +$38.1M 5.18% 3

Other funds holding HCA

Lee, Danner & Bass's HCA Position: Q2 2026 in Review

Lee, Danner & Bass increased its HCA Healthcare (HCA) stake by 0.74% in Q2 2026, buying an estimated $1.21M and bringing the position to 390,240 shares worth $152M. The position accounts for 8.77% of the portfolio, ranked #1.

Lee, Danner & Bass first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q1 2026. 424 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Lee, Danner & Bass held 390,240 shares of HCA Healthcare worth $152M as of Q2 2026.
  • Lee, Danner & Bass bought 2,863 HCA Healthcare shares in Q2 2026, an estimated $1.21M.
  • HCA Healthcare made up 8.77% of Lee, Danner & Bass's portfolio in Q2 2026, its #1 holding.
  • Lee, Danner & Bass first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Lee, Danner & Bass's HCA Healthcare position peaked at $183M in Q1 2026.
  • 424 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.